Related references
Note: Only part of the references are listed.Reinfection With SARS-CoV-2: Implications for Vaccines
Jeffrey Cohen et al.
CLINICAL INFECTIOUS DISEASES (2021)
Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study
Philippe Colson et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)
Evidence of SARS-CoV-2 re-infection with a different genotype
Philippe Colson et al.
JOURNAL OF INFECTION (2021)
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
Sophie Amrane et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Jean-Christophe Lagier et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Seasonal coronavirus protective immunity is short-lasting
Arthur W. D. Edridge et al.
NATURE MEDICINE (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of infection history on dengue virus infection and pathogenicity
Tim K. Tsang et al.
NATURE COMMUNICATIONS (2019)
Vaccine-attributable severe dengue in the Philippines
Annelies Wilder-Smith et al.
LANCET (2019)
Original antigenic sin: A comprehensive review
Anup Vatti et al.
JOURNAL OF AUTOIMMUNITY (2017)
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
Maria G. Guzman et al.
ARCHIVES OF VIROLOGY (2013)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)